Related Experiment Video
Updated: Dec 28, 2025
Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
Published on: February 23, 2024
Mechanisms of cancer inhibition by anti-oxidant nutrients
1Department of Oral Medicine and Diagnostic Sciences, Harvard School of Dental Medicine, Boston, MA 02115, USA.
Abstract:
The cancer inhibitory properties of anti-oxidant micronutrients have been well established in experimental animal models and cell culture studies. Human studies have also tended to indicate an inhibition of various forms of cancer and the regression of some precancerous lesions. The biological mechanisms for cancer inhibition and regression are now gradually becoming understood, and the anti-oxidant nutrients appear to act through a number of pathways common to most of the agents studied. These various micronutrients appear to act through a complex group of "common pathways" of anticancer activity based upon three major mechanisms: (1) tumour inhibition by immune cytokines; (2) stimulation of cancer suppressor genes, such as "wild type" p53, and diminished expression or dysregulation of oncogenes such as mutant p53 and H-ras; (3) inhibition of tumour angiogenesis through the inhibition of angiogenesis-stimulating factors such as TGF alpha. Retinoid action differs, in some respects, from other micronutrient anticancer mechanisms and appears to relate to its stimulation of cellular differentiation and resultant apoptosis of neoplastic cells. Combinations of anti-oxidant nutrients have been shown to be synergistic in their anticancer activity, probably due to their optimal anticancer activity at different oxygen potentials. Selectivity in the action on cancer cells, as opposed to normal cells, is a major feature of the anti-oxidant micronutrients.
Insights
Antioxidant micronutrients show promise in inhibiting cancer and regression of precancerous lesions. These nutrients act through common pathways, including immune support, gene regulation, and inhibiting tumor growth, with selective action on cancer cells.
Area of Science:
- Oncology
- Nutritional Science
- Molecular Biology
Background:
- Antioxidant micronutrients demonstrate cancer inhibitory properties in preclinical and human studies.
- Evidence suggests these nutrients can inhibit various cancers and regress precancerous lesions.
- Understanding the biological mechanisms of their action is crucial for therapeutic development.
Purpose of the Study:
- To elucidate the common biological pathways through which antioxidant micronutrients exert anticancer effects.
- To detail the specific molecular mechanisms involved in tumor inhibition, gene regulation, and angiogenesis.
- To explore the unique role of retinoids in cancer therapy via differentiation and apoptosis.
Main Methods:
- Review of experimental animal models and cell culture studies on antioxidant micronutrients.
- Analysis of human studies investigating cancer inhibition and lesion regression.
- Examination of molecular mechanisms including immune cytokine pathways, gene expression (p53, oncogenes), and angiogenesis factors (TGF-alpha).
Main Results:
- Antioxidant micronutrients act via common pathways: immune cytokine modulation, stimulation of tumor suppressor genes (e.g., wild-type p53), and inhibition of oncogenes (e.g., mutant p53, H-ras).
- Tumor angiogenesis is inhibited by targeting angiogenesis-stimulating factors like TGF-alpha.
- Retinoids promote cellular differentiation and apoptosis of neoplastic cells, distinct from other micronutrients.
Conclusions:
- Antioxidant micronutrients exhibit synergistic anticancer activity, likely due to varied optimal oxygen potentials.
- These nutrients display selectivity, targeting cancer cells while sparing normal cells.
- Further research into combinations and mechanisms could lead to novel cancer prevention and treatment strategies.
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
02:59Cancer Prevention
Some...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:34Inhibition of Cdk Activity
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...